Holen Sie sich die Stockscreener-App
37.53
0.67%
0.25
Vorhandelsmarkt:
37.06
-0.47
-1.25%
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
What's Happening With French Biotech Abivax Stock On Wednesday? - Benzinga
Viking Therapeutics Faces Pressure as Rival Obesity Drug Data Emerges - AD HOC NEWS
Major Investors Pile Into Viking Therapeutics Stock - AD HOC NEWS
Looking At Viking Therapeutics's Recent Unusual Options Activity - Benzinga
460,415 Shares in Viking Therapeutics, Inc. $VKTX Acquired by Jump Financial LLC - MarketBeat
Franklin Resources Inc. Has $703,000 Stock Holdings in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics (VKTX): Valuation Check After Faster-Than-Expected Enrollment in Key Obesity Drug Trial - simplywall.st
Norges Bank Takes $46.85 Million Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics: Analysts Project Stock Could More Than Double - AD HOC NEWS
Viking Therapeutics: Prepping For A Critical 2026 - Seeking Alpha
Viking Therapeutics (NASDAQ:VKTX) Shares Up 9.4%Here's Why - MarketBeat
Schroder Investment Management Group Buys 150,470 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Will Viking Therapeutics Inc. stock outperform Nasdaq index2025 AllTime Highs & Verified Chart Pattern Trade Signals - Newser
Will Viking Therapeutics Inc. stock outperform international peersEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
What's Up With The Jump In Viking Therapeutics Stock? - Benzinga
The FDA Is Shaking Things Up; Biotech, Research Stocks Diverge - Investor's Business Daily
How Viking Therapeutics Inc. (1VT) stock expands through international marketsTrade Ideas & Weekly Breakout Opportunity Watchlist - Newser
What consensus target says about Viking Therapeutics Inc. (1VT) stockMarket Performance Summary & Daily Entry Point Alerts - Newser
Will Viking Therapeutics Inc. stock benefit from sector rotationJuly 2025 Big Picture & Low Drawdown Trading Techniques - Newser
Viking Therapeutics Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
How Viking Therapeutics Inc. stock responds to policy changesBuy Signal & Growth Oriented Trade Recommendations - Newser
Viking Therapeutics Stock Gains Momentum on Clinical Progress - AD HOC NEWS
42,134 Shares in Viking Therapeutics, Inc. $VKTX Purchased by Scotia Capital Inc. - MarketBeat
Why Viking Therapeutics Inc. stock appeals to analysts2025 Pullback Review & Stock Portfolio Risk Management - Newser
Will Viking Therapeutics Inc. (1VT) stock deliver compounding returnsJuly 2025 Setups & Expert Curated Trade Setups - Newser
What margin trends mean for Viking Therapeutics Inc. stockEntry Point & Fast Moving Market Watchlists - Newser
Is There a Future for Viking Therapeutics? - AOL.com
The Bull Case For Viking Therapeutics (VKTX) Could Change Following Early Completion and Positive Data in Obesity Trial - simplywall.st
Viking Therapeutics Emerges as a Prime Acquisition Candidate Amid Obesity Drug Advancements - AD HOC NEWS
XTX Topco Ltd Acquires Shares of 36,199 Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics, Inc. (VKTX) Options Chain - Yahoo! Finance Canada
Why Viking Therapeutics Inc. (1VT) stock attracts HNW investorsQuarterly Trade Report & Proven Capital Preservation Methods - Newser
VKTX Stock Rises 34% in Three Months: Here's What You Should Know - sharewise.com
Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating - MSN
Viking Therapeutics Emerges as a Prime Acquisition Target Following Trial Success - AD HOC NEWS
(VKTX) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Viking Therapeutics Stock Gains Momentum on Clinical Trial Milestone - Ad-hoc-news.de
Assessing Viking Therapeutics (VKTX) Valuation After Recent Share Price Recovery - Yahoo Finance
Ensign Peak Advisors Inc Trims Stake in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics (VKTX): Evaluating Valuation After Key Phase 3 Obesity Trial Milestone and New Clinical Data - Sahm
Viking Therapeutics: A Clash of Convictions - Ad-hoc-news.de
SG Americas Securities LLC Makes New $379,000 Investment in Viking Therapeutics, Inc. $VKTX - MarketBeat
Tejara Capital Ltd Purchases 30,097 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
What drives Viking Therapeutics Inc stock pricePrice Channel Trading & Small Entry Cost Trading - earlytimes.in
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? - Finviz
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Is Viking Therapeutics Inc. stock a good choice for value investorsRisk Management & Low Drawdown Momentum Ideas - BỘ NỘI VỤ
Why Viking Therapeutics Inc. stock remains undervaluedJuly 2025 Sentiment & Daily Stock Trend Watchlist - BỘ NỘI VỤ
Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 - Finviz
Viking Therapeutics: A Stock at a Crossroads - Ad-hoc-news.de
Market Catalysts: What momentum indicators show for Viking Therapeutics Inc. stockJuly 2025 Sentiment & High Return Trade Guides - moha.gov.vn
12,059 Shares in Viking Therapeutics, Inc. $VKTX Acquired by Entropy Technologies LP - MarketBeat
Steward Partners Investment Advisory LLC Boosts Stock Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics to Participate at the Piper Sandler 37th Ann - GuruFocus
Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference - Nasdaq
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):